Celia Fernández-Rubio

Universidad de León

H指数:14

被引数:622

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Immunocompetent Hepatic Organoid Model Reveals Conserved Hepatic Immune Dysregulation During Leishmania donovani Infection

免疫活性肝类器官模型揭示利什曼原虫感染期间肝免疫失调的保守性

International Journal of Molecular Sciences

IF4.9

2026-08-110

Antileishmanial and Immunomodulatory Activity of Paclitaxel and Docetaxel Combined with Miltefosine and Paromomycin

帕克他赛和多西他赛联合米特fosine和巴龙霉素的抗利什曼原虫和免疫调节活性

International Journal of Molecular Sciences

IF4.9

2026-03-290

OAAI

Leishmanicidal Action of the Peptides 19-4LF, 19-2.5 and 19-2.5LF Topically Administered on Cutaneous Lesions Caused by Leishmania major

利什曼虫杀灭作用：局部给药于曲性病变的肽19-4LF、19-2.5和19-2.5LF，由Leishmania major引起

Pharmaceutics

IF5.5

2026-03-080

OAAI

Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

基于小鼠肝类器官的高通量筛选平台和利什曼原虫感染致病模型开发

International Journal of Molecular Sciences

IF4.9

2026-03-040

OAAI

Discovery of Potential Antileishmanial Compounds Through Phenotypic Screening of an Alkaloid Library

通过表型筛选碱性化合物库发现潜在的抗利什曼原虫化合物

Molecules 2025, Vol. 30, Page 4210

IF4.6

2025-10-280

OAAI

The Role of BRCT Domain from LmjPES in Leishmania major Pathogenesis

LmjPES中BRCT结构域在利什曼原虫主要致病中的作用

Biomolecules 2025, Vol. 15, Page 1191

IF4.8

2025-08-200

PRE

Promising aryl selenoate derivatives as antileishmanial agents and their effects on gene expression

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2024-04-030

Neglected Zoonotic Diseases: Advances in the Development of Cell-Penetrating and Antimicrobial Peptides against Leishmaniosis and Chagas Disease

PATHOGENS

IF3.3

2023-07-154

OAAI

BRCT Domains: Structure, Functions, and Implications in Disease-New Therapeutic Targets for Innovative Drug Discovery against Infections

PHARMACEUTICS

IF5.5

2023-06-279

OAAI

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

PHARMACEUTICS

IF5.5

2022-11-208

OAAI

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome

BIOMEDICINES

IF3.9

2020-10-269

OAAI

Structural characterization by scattering and spectroscopic methods and biological evaluation of polymeric micelles of poloxamines and TPGS as nanocarriers for miltefosine delivery

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2020-03-0128

PREAI

Leishmanicidal Activity of Isoselenocyanate Derivatives

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2019-02-0127

OAAI

Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions

JOURNAL OF DERMATOLOGICAL SCIENCE

IF4

2018-10-0117

OAAI

Leishmanicidal Activities of Novel Methylseleno-Imidocarbamates

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2015-09-0125

OAAI

First total synthesis and antileishmanial activity of (Z)-16-methyl-11-heptadecenoic acid, a new marine fatty acid from the sponge Dragmaxia undata

CHEMISTRY AND PHYSICS OF LIPIDS

IF2.8

2011-02-0112

OAAI

DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery

apicomplexan寄生虫中的DNA拓扑异构酶: 药物发现的有希望的目标

PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

IF3.5

2010-03-0351

OAAI

Novel Findings on Trypanosomatid Chemotherapy Using DNA Topoisomerase Inhibitors

MINI-REVIEWS IN MEDICINAL CHEMISTRY

IF3.3

2009-06-016

PREAI

Butyric acid-based feed additives help protect broiler chickens from Salmonella Enteritidis infection

POULTRY SCIENCE

IF4.2

2009-05-01218

OAAI

Celia Fernández-Rubio

个人简介

教育背景

工作经历

荣誉奖项

研究方向